Peter Arlett
14PUBLICATIONS
44CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (14)
Sort by Publication Date:
|Oct 28, 2025
A Fast Path from Innovation to Safe and Effective Medicines.Peter Arlett, Falk Ehmann, Ralf Herold
|Oct 22, 2024
Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives.Andrew E Beck, Melissa Kampman, Cindy Huynh
|Jul 04, 2024
Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases.Stefanie Prilla, Sophie Groeneveld, Alexandra Pacurariu
|Nov 16, 2020
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.Andrej Segec, Jim Slattery, Daniel R Morales
|Mar 13, 2020
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.Jane Moseley, Spiros Vamvakas, Michael Berntgen
|Jan 20, 2020
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee.Robert Flynn, Karin Hedenmalm, Tarita Murray-Thomas
Pageof 3
Frequent Collaborators
4 joint publications
Xavier Kurz
3 joint publications
Patrice Verpillat
2 joint publications
Steffen Thirstrup
2 joint publications
Frank Pétavy
2 joint publications
Jim Slattery
2 joint publications
Alexandra Pacurariu
2 joint publications
Bruno Sepodes
1 joint publications
Marie L De Bruin
1 joint publications
Robert Flynn
1 joint publications
Karin Hedenmalm